Back
Verisk Analytics Vs. SpringWorks Therapeutics Industry Stock Comparison
Sell
49
VRSK
Verisk Analytics
Last Price:
$285.19
Seasonality Move:
5.01%
Sell
15
SWTX
SpringWorks Therapeutics
Last Price:
$39.07
Seasonality Move:
5.59%
Sell
49
Verisk Analytics (VRSK)
is a Sell
Is Verisk Analytics a Buy, Sell or Hold?
-
The current Verisk Analytics [VRSK] share price is $284.99. The Score for VRSK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
VRSK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
-
The current SpringWorks Therapeutics [SWTX] share price is $39.09. The Score for SWTX is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
SWTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
VRSK Stock Price Chart
What is Verisk Analytics's stock price today?
-
The Verisk Analytics share price today is $284.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRSK is experiencing selling pressure, which indicates risk of future bearish movement.
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $39.09Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.
VRSK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.28 | Buy |
Relative Strength Index (14 RSI): | 42.25 | Sell |
Chaikin Money Flow: | -1970574 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (287.64 - 298.94) | Sell |
Bollinger Bands (100): | (279.01 - 294.69) | Sell |
SWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.89 | Sell |
Relative Strength Index (14 RSI): | 34.32 | Sell |
Chaikin Money Flow: | -2397813 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.98 - 52.54) | Sell |
Bollinger Bands (100): | (35.09 - 50.17) | Sell |
VRSK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 296.19 | Sell |
20-day SMA: | 292.12 | Sell |
50-day SMA: | 291.59 | Sell |
200-day SMA: | 278.55 | Buy |
8-day EMA: | 294.77 | Sell |
20-day EMA: | 293.45 | Sell |
50-day EMA: | 290.74 | Sell |
200-day EMA: | 276.74 | Buy |
SWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.51 | Sell |
20-day SMA: | 47.73 | Sell |
50-day SMA: | 47.6 | Sell |
200-day SMA: | 39.15 | Sell |
8-day EMA: | 44.08 | Sell |
20-day EMA: | 46.76 | Sell |
50-day EMA: | 46.56 | Sell |
200-day EMA: | 41.23 | Sell |
Verisk Analytics Earnings Growth & VRSK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.87 per share.
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.
Verisk Analytics Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
SpringWorks Therapeutics Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |